Kleos Satellite in Orbit. Source: Kleos Space
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Kleos Space (KSS) seeks bankruptcy adjudication in a relevant commercial district court in Luxembourg
  • The company’s mandated broker was unable to secure the required commitments for a previously announced converting note facility
  • The financier declined to extend forbearance on the loan facility, making loans and accrued amounts due immediately
  • In the meantime, trading in Kleos’ securities remains suspended
  • KSS shares last traded at 10 cents

Space-powered defence and intelligence technology company Kleos Space (KSS) has commenced bankruptcy proceedings.

The company announced its mandated broker could not secure the necessary commitments to progress a converting note facility previously announced to the market on June 6, 2023.

As a result, the loans and other accrued amounts were made due immediately.

Kleos’ Board announced it had no choice but to acknowledge the company’s inability to meet its financial commitments.

The company has since petitioned the relevant commercial district court in Luxembourg for bankruptcy adjudication. Kleos is now working on the necessary documentation to support its application.

In the meantime, trading in Kleos’ securities remains suspended.

KSS shares last traded at 10 cents.

KSS by the numbers
More From The Market Online

Week 17 Wrap: BHP-Anglo deal helps push down ASX; US data of concern but AI bulls happy

The big thematics and headlines that drove the ASX this week, plus, the headlines I think…
The Market Online Video

Market Close: ASX signs off on a sigh with all sectors red-lining

The ASX200 finished 1.3 per cent down with every sector in the red and Industrials and Real Estate brittle and bruised as bot…
The Market Online Video

Market Update: ASX on red alert with all sectors below the surface

The ASX200 is trading down around 1.1% with all eleven sectors in the red. Real-estate has…

ResMed spikes on robust results and global growth spurt

ResMed shares have climbed following the release of the company's strong Third Quarter FY2024 results.